Style | Citing Format |
---|---|
MLA | Yaghobee S, et al.. "Evaluation of Topical Erythropoietin Application on the Healing Outcome of Gingival Graft Recipient Site; a Randomized Controlled Clinical Trial." BMC Oral Health, vol. 21, no. 1, 2021, pp. -. |
APA | Yaghobee S, Rouzmeh N, Taheri M, Aslroosta H, Mahmoodi S, Mohammadnejad Hardoroodi M, Soleimanzadeh Azar P, Khorsand A (2021). Evaluation of Topical Erythropoietin Application on the Healing Outcome of Gingival Graft Recipient Site; a Randomized Controlled Clinical Trial. BMC Oral Health, 21(1), -. |
Chicago | Yaghobee S, Rouzmeh N, Taheri M, Aslroosta H, Mahmoodi S, Mohammadnejad Hardoroodi M, Soleimanzadeh Azar P, Khorsand A. "Evaluation of Topical Erythropoietin Application on the Healing Outcome of Gingival Graft Recipient Site; a Randomized Controlled Clinical Trial." BMC Oral Health 21, no. 1 (2021): -. |
Harvard | Yaghobee S et al. (2021) 'Evaluation of Topical Erythropoietin Application on the Healing Outcome of Gingival Graft Recipient Site; a Randomized Controlled Clinical Trial', BMC Oral Health, 21(1), pp. -. |
Vancouver | Yaghobee S, Rouzmeh N, Taheri M, Aslroosta H, Mahmoodi S, Mohammadnejad Hardoroodi M, et al.. Evaluation of Topical Erythropoietin Application on the Healing Outcome of Gingival Graft Recipient Site; a Randomized Controlled Clinical Trial. BMC Oral Health. 2021;21(1):-. |
BibTex | @article{ author = {Yaghobee S and Rouzmeh N and Taheri M and Aslroosta H and Mahmoodi S and Mohammadnejad Hardoroodi M and Soleimanzadeh Azar P and Khorsand A}, title = {Evaluation of Topical Erythropoietin Application on the Healing Outcome of Gingival Graft Recipient Site; a Randomized Controlled Clinical Trial}, journal = {BMC Oral Health}, volume = {21}, number = {1}, pages = {-}, year = {2021} } |
RIS | TY - JOUR AU - Yaghobee S AU - Rouzmeh N AU - Taheri M AU - Aslroosta H AU - Mahmoodi S AU - Mohammadnejad Hardoroodi M AU - Soleimanzadeh Azar P AU - Khorsand A TI - Evaluation of Topical Erythropoietin Application on the Healing Outcome of Gingival Graft Recipient Site; a Randomized Controlled Clinical Trial JO - BMC Oral Health VL - 21 IS - 1 SP - EP - PY - 2021 ER - |